kimiabiosciences

[kimiabiosciences1]

Kimia Biosciences Ltd™ is engaged in manufacturing of bulk drugs addressing to various high potential therapeutic segments and has envisaged high growth plans through infrastructure creation and CMS.

[kimiabiosciences1]

Azelnidipine is a dihydropyridine calcium channel blocker. it has a gradual onset and has a long-lasting hypotensive effect, with minimal increase in heart rate [L1379]. It is currently being studied for post-ischemic stroke management [L1380].Azelnidipine is a vasodilator that induces a gradual decrease in blood pressure in hypertensive patients. Unlike other members of its drug class, azelnidipine does not induce reflex tachycardia due to vasodilation. This is likely due to the fact that it elicits a gradual fall in blood pressure.

[kimiabiosciences1]

Benfotiamine is a derivative of vitamin B1. It was developed in Japan specifically to treat Korsakoff's syndrome Benfotiamine reduces the extra biosynthesis and accumulation of a number of glucose metabolites, including glyceraldeyde-3-phosphate and dihydroxyacetone phosphate. Elevated levels of those glucose intermediates function as a trigger to most of the mechanisms accountable for hyperglycemia-caused cell damage.

[kimiabiosciences1]

We manufactures Montelukast Sodium. It is mainly used to treat nasal congestion, but may also be useful in discussing hypotension and shock, hypotension during spinal anesthesia

[kimiabiosciences1]

PrucaloprideSuccinate is indicated for the treatment of chronic idiopathic constipation (CIC) in adults.CIC is one of the most common chronic functional gastrointestinal disorders worldwide.